Back to your search result

Description

A cell-permeable IKK-2 inhibitor that selectively blocks IkappaBalpha phosphorylation (IC50 ~250 nM) and prevents the induction of NF-kappaB p65 nuclear translocation. Reported to suppress neoplastic proliferation of mast cells with constitutively activated c-kit receptor. Shown to offer cardioprotection by reducing IL-1beta and MCP-1 production (IC50<1 µ,M) in cardiomyocytes, and ameliorate insulin resistance in diabetic KKAy mice by regulating adiponectin release., A cell-permeable salicylamide compound that acts as an IKK-2 inhibitor by selectively blocking IkappaBalpha phosphorylation (IC50 ~ 250 nM) and thereby prevents the induction of NF-kappaB p65 nuclear translocation. Shown to offer cardioprotection by reducing IL-1beta and MCP-1 production (IC50<1 µ,M) in cardiomyocytes, and ameliorate insulin resistance in KKAy mice by regulating adiponectin release.